Table 1.
Baseline patient data
| Characteristic | Total (n=59) | Patients with HL (n=39) | Patients without HL (n=20) | P |
|---|---|---|---|---|
| Age | 41.8±9.2 | 43.0±8.9 | 39.4±9.5 | 0.149 |
| Male:female ratio | 1.27 | 1.29 | 1.22 | 0.918 |
| Duration of hemodialysis (years) | 3.4±2.9 | 4.1±3.2 | 1.9±1.3 | 0.006 |
| Presence of HTN, DM, or both, percentage | 94.9 | 94.9 | 95.0 | 0.983 |
| Serum potassium (mmol/L) | 4.7±0.7 | 4.6±0.7 | 4.9±0.7 | 0.119 |
| Serum sodium (mmol/L) | 141.7±8.8 | 141.3±8.9 | 142.5±8.6 | 0.604 |
| Serum calcium (mg/dL) | 4.1±0.6 | 4.1±0.5 | 4.0±0.6 | 0.506 |
| Serum blood urea (mg/dL) | 194.8±39.9 | 194.9±42.0 | 194.7±39.4 | 0.983 |
| Serum creatinine (mg/dL) | 9.5±1.5 | 9.6±1.5 | 9.3±1.6 | 0.529 |
| Sessions of dialysis (/week) | ||||
| 2 | 34 (57.6) | 24 (70.6) | 10 (29.4) | 0.419 |
| 3 | 25 (42.4) | 15 (60.0) | 10 (40.0) | |
| Duration of chronic renal failure (years) | ||||
| <2 | 27 (45.8) | 16 (59.3) | 11 (40.7) | 0.006 |
| 25 | 19 (32.2) | 10 (52.6) | 9 (47.4) | |
| >5 | 13 (22.0) | 13 (100.0) | 0 |
Data are presented as mean±SD or n (%) unless otherwise indicated. HL: Hearing loss, HTN: Hypertension, DM: Diabetes mellitus, SD: Standard deviation